Leukemia News and Research

RSS

Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.

Exploring biological mechanisms behind the link between obesity prior to pregnancy and elevated risk of pediatric ALL

Published in Leukemia Research, University of Minnesota Medical School researchers explored the possible biological mechanisms that could explain the association between being overweight or obese prior to pregnancy and the increased risk of acute lymphoblastic leukemia (ALL) in children.

28 Sep 2022

Live imaging and cellular barcoding reveal how new stem cells are vetted for quality

Using live imaging and cellular barcoding, researchers in the Stem Cell Program at Boston Children's Hospital have glimpsed how new stem cells -; in this case, blood stem cells -; are vetted for quality soon after they're born.

28 Sep 2022

Successful implementation strategy to scale-up PEWS for children with cancer

Pediatric Early Warning Systems (PEWS)-;bedside tools used by nurses to assess the health of hospitalized children and identify urgent medical issues-; are not widely used in resource-limited hospitals, in part due to challenges with implementation.

26 Sep 2022

Omicron BA.1 breakthrough infection in vaccinated individuals recall memory B cells to confer immunity

In a new study, researchers followed up with individuals vaccinated with a COVID-19 vaccine based on the mRNA platform up to six months following Omicron BA.1 breakthrough infection to trace the evolution of their antibody immunity.

26 Sep 2022

UVA's new discovery could help ramp up production of blood-clotting platelets

A new discovery from the University of Virginia School of Medicine could let doctors ramp up production of blood-clotting platelets on demand, a timely finding following the Red Cross' declaration earlier this year of a national blood "crisis."

23 Sep 2022

Study reveals a higher risk of cancer mortality in incarcerated adults

New research from Yale Cancer Center reveals a higher risk of cancer mortality in incarcerated adults, as well as among those diagnosed with cancer in the first year after release from prison.

16 Sep 2022

New abortion laws jeopardize cancer treatment for pregnant patients

As abortion bans go into effect across a contiguous swath of the South, cancer physicians are wrestling with how new state laws will influence their discussions with pregnant patients about what treatment options they can offer.

16 Sep 2022

Treating the cerebrospinal fluid to protect the brain from chemotherapy's toxic effects

Up to three quarters of patients receiving cancer chemotherapy suffer from "chemo brain" -; a long-term side effect that makes it harder to remember things, maintain attention, and learn new information. When it strikes children, whose brains are still developing, their schoolwork and self-esteem may suffer.

13 Sep 2022

Gut commensal bacteria promote the development of virus-induced cancer by suppressing the immune system

Gut bacteria have a profound impact on health by aiding digestion, providing nutrients and metabolites, and working with the immune system to fend off pathogens.

13 Sep 2022

St. Baldrick's Scholar grant awarded to CU researcher for investigating new drug to treat infant leukemia

As part of its ongoing efforts to eradicate childhood cancers, the St. Baldrick's Foundation has awarded University of Colorado Cancer Center member Kelly Faulk, MD, a St. Baldrick's Scholar grant to investigate a new method for treating infant leukemia.

9 Sep 2022

Comprehensive genetic architecture atlas compiled for mutant RAS genes in cancers

Researchers at the Johns Hopkins Kimmel Cancer Center, three other cancer centers and the Johns Hopkins Bloomberg School of Public Health compiled a comprehensive genetic architecture atlas for mutant RAS genes in human cancers.

8 Sep 2022

Cancer risk higher among children born after frozen-thawed embryo transfer

In a recent PLOS Medicine journal study, scientists have documented that children born after ART, particularly FET, are at an increased risk of developing childhood cancer than those born after spontaneous conception and fresh embryo transfer.

8 Sep 2022

Study provides a comprehensive view of the genomics of all childhood ALL subtypes

Scientists have created a roadmap of the genetic mutations present in the most common childhood cancer, acute lymphoblastic leukemia (ALL).

1 Sep 2022

Simple blood test may identify patients at high risk of neurotoxic complications after CAR-T cell therapy

Cell-based immunotherapy called CAR-T cell therapy has revolutionized the treatment of several cancers.

1 Sep 2022

How does origin impact antiviral immune response?

A new study observed differential antiviral responses in Indian and European individuals.

1 Sep 2022

Leukemia drug successfully disrupts HER2-positive brain metastasis in animal studies

In animal studies led by researchers at Duke Cancer Institute, a drug approved to treat leukemia successfully disrupted the ability of HER2-positive breast cancer tumors from colonizing the brain.

30 Aug 2022

Immune cells beyond CAR-T cells affect the durability of response to BCMA CAR T therapy in myeloma

Patients with myeloma whose tumor immune microenvironments had a more diverse baseline T-cell repertoire, fewer markers of immune cell exhaustion, and distinct changes to immune cell populations were more likely to have longer progression-free survival (PFS) after treatment with BCMA-targeted T-cell therapy.

30 Aug 2022

Leukemia News and Research

Further Reading

Exploring biological mechanisms behind the link between obesity prior to pregnancy and elevated risk of pediatric ALL

Live imaging and cellular barcoding reveal how new stem cells are vetted for quality

Successful implementation strategy to scale-up PEWS for children with cancer

Omicron BA.1 breakthrough infection in vaccinated individuals recall memory B cells to confer immunity

UVA's new discovery could help ramp up production of blood-clotting platelets

Study reveals a higher risk of cancer mortality in incarcerated adults

New abortion laws jeopardize cancer treatment for pregnant patients

Treating the cerebrospinal fluid to protect the brain from chemotherapy's toxic effects

Gut commensal bacteria promote the development of virus-induced cancer by suppressing the immune system

St. Baldrick's Scholar grant awarded to CU researcher for investigating new drug to treat infant leukemia

Comprehensive genetic architecture atlas compiled for mutant RAS genes in cancers

Cancer risk higher among children born after frozen-thawed embryo transfer

Study provides a comprehensive view of the genomics of all childhood ALL subtypes

Simple blood test may identify patients at high risk of neurotoxic complications after CAR-T cell therapy

How does origin impact antiviral immune response?

Leukemia drug successfully disrupts HER2-positive brain metastasis in animal studies

Immune cells beyond CAR-T cells affect the durability of response to BCMA CAR T therapy in myeloma

Anonymous $5.75 million gift will enable UVA to fight against rare blood cancers

Researchers discover a new class of more potent and less toxic drugs for leukemia patients

Unconventional oil and gas development exposure increases the risk for acute lymphoblastic leukemia in children

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News